FDA OKs Symplicity Renal Denervation System for Hypertension

After a mixed FDA panel review in August, the agency has approved Medtronic's Symplicity Spyral renal denervation system for treatment of hypertension.

Related Keywords

Raymond Townsend ,David Kandzari ,Medtronic Symplicity Spyral ,Symplicity Spyral ,Otsuka Medical Devices Co Ltd ,Recor Medical Inc ,University Of Pennsylvania School Medicine ,Drug Administration ,Circulatory System Devices Panel ,Global Clinical Program ,Piedmont Heart Institute ,Medtronic ,System Devices Panel ,Medscape Medical ,Clinical Program ,Pennsylvania School ,Paradise Ultrasound Renal Denervation ,Hypertension ,Antihypertensive ,Blood ,Renal Denervation ,Myocardial Infarction ,Physician Patient Decision Making ,Patient Counseling ,Rovider Patient Communication ,Linician Patient Relationship Counseling ,Hysician Patient Collaboration ,Patient Preferences ,Patient Centered Care ,Partners In Care ,Are Planning ,Activate ,Mpower ,Arteries ,Us Food And Drug Administration ,Nited States Food A ,